June 2026

Ninth JCA-AACR Special Joint Conference on Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers

TNX-1700, a First-in-Class CXCR4 Partial Agonist, Normalizes Myelopoiesis, and Enhances Anti-PD-1 Therapy in Gastric Cancer